Catalyst Pharmaceuticals Inc (CPRX)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 470,114 | 375,630 | 237,788 | 192,354 | 112,376 |
| Total stockholders’ equity | US$ in thousands | 387,881 | 300,421 | 206,831 | 169,598 | 87,630 |
| Financial leverage ratio | 1.21 | 1.25 | 1.15 | 1.13 | 1.28 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $470,114K ÷ $387,881K
= 1.21
The financial leverage ratio for Catalyst Pharmaceuticals Inc has shown some fluctuation over the past five years. The ratio was at its highest in 2019 at 1.28, then decreased in the following years to 1.13 in 2020 and further to 1.15 in 2021. However, there was an increase in the ratio to 1.25 in 2022 before slightly declining to 1.21 in 2023. This indicates that the company has been using more debt to finance its assets in recent years, with a peak in 2019. It is important for investors and stakeholders to closely monitor changes in the financial leverage ratio as it can have implications for the company's financial health and risk profile.
Peer comparison
Dec 31, 2023